Other research investigated multiple biomarkers in metastatic breast cancer patients, including serum neuron-specific enolase (NSE) level, serum MMP-9 level, and serum HER2 extracellular domain level (ECD) [108]. Here, ERBB2 is linked to breast carcinoma.